Annual Working Capital
$181.56 M
+$64.89 M+55.61%
31 December 2023
Summary:
Inozyme Pharma annual working capital is currently $181.56 million, with the most recent change of +$64.89 million (+55.61%) on 31 December 2023. During the last 3 years, it has risen by +$40.56 million (+28.76%). INZY annual working capital is now at all-time high.INZY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$122.59 M
-$14.83 M-10.79%
30 September 2024
Summary:
Inozyme Pharma quarterly working capital is currently $122.59 million, with the most recent change of -$14.83 million (-10.79%) on 30 September 2024. Over the past year, it has dropped by -$65.99 million (-34.99%). INZY quarterly working capital is now -34.99% below its all-time high of $188.58 million, reached on 30 September 2023.INZY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.6% | -35.0% |
| 3 y3 years | +28.8% | +0.8% |
| 5 y5 years | +344.2% | - |
INZY Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +75.1% | -35.0% | +38.8% |
| 5 y | 5 years | at high | +344.2% | -35.0% | +177.2% |
| alltime | all time | at high | +344.2% | -35.0% | +177.2% |
Inozyme Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $122.59 M(-10.8%) |
| June 2024 | - | $137.42 M(-15.1%) |
| Mar 2024 | - | $161.92 M(-10.8%) |
| Dec 2023 | $181.56 M(+55.6%) | $181.56 M(-3.7%) |
| Sept 2023 | - | $188.58 M(+43.4%) |
| June 2023 | - | $131.51 M(+8.2%) |
| Mar 2023 | - | $121.57 M(+4.2%) |
| Dec 2022 | $116.68 M | $116.68 M(-12.1%) |
| Sept 2022 | - | $132.79 M(-7.3%) |
| June 2022 | - | $143.18 M(+62.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $88.32 M(-14.8%) |
| Dec 2021 | $103.71 M(-26.5%) | $103.71 M(-14.7%) |
| Sept 2021 | - | $121.64 M(-9.2%) |
| June 2021 | - | $133.99 M(-5.1%) |
| Mar 2021 | - | $141.21 M(+0.1%) |
| Dec 2020 | $141.01 M(+218.8%) | $141.01 M(-8.5%) |
| Sept 2020 | - | $154.16 M(+166.1%) |
| June 2020 | - | $57.93 M(-17.3%) |
| Mar 2020 | - | $70.05 M(+58.4%) |
| Dec 2019 | $44.22 M(+8.2%) | $44.22 M |
| Dec 2018 | $40.88 M | - |
FAQ
- What is Inozyme Pharma annual working capital?
- What is the all time high annual working capital for Inozyme Pharma?
- What is Inozyme Pharma annual working capital year-on-year change?
- What is Inozyme Pharma quarterly working capital?
- What is the all time high quarterly working capital for Inozyme Pharma?
- What is Inozyme Pharma quarterly working capital year-on-year change?
What is Inozyme Pharma annual working capital?
The current annual working capital of INZY is $181.56 M
What is the all time high annual working capital for Inozyme Pharma?
Inozyme Pharma all-time high annual working capital is $181.56 M
What is Inozyme Pharma annual working capital year-on-year change?
Over the past year, INZY annual working capital has changed by +$64.89 M (+55.61%)
What is Inozyme Pharma quarterly working capital?
The current quarterly working capital of INZY is $122.59 M
What is the all time high quarterly working capital for Inozyme Pharma?
Inozyme Pharma all-time high quarterly working capital is $188.58 M
What is Inozyme Pharma quarterly working capital year-on-year change?
Over the past year, INZY quarterly working capital has changed by -$65.99 M (-34.99%)